AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHNEIDER, B.
Right arrow Articles by SANTULLI, T. V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SCHNEIDER, B.
Right arrow Articles by SANTULLI, T. V.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

WILMS' TUMOR: THE EVOLUTION OF A TREATMENT PROGRAM

B. SCHNEIDER , R. H. SAGERMAN , J. A. WOLFF , and T. V. SANTULLI

Forty-four children with Wilms' tumor were seen in the combined Pediatric Tumor Clinic of the Babies Hospital, Columbia-Presbyterian Medical Center, from 1952 through 1965. This period of time was chosen for evaluation because the philosophy of the pediatric, surgical and radiotherapeutic members of the Tumor Clinic remained stable throughout this interval.

The evolution of the treatment program for Wilms' tumor is traced.

Careful analysis of patients with gross total tumor removal treated additionally with radiation therapy to the tumor bed versus such radiotherapy plus multiple prophylactic courses of Dactinomycin suggests a clinically important increase in survival rate with the latter program.

The value of routine postoperative irradiation of the tumor bed following gross total removal of the tumor is questioned in light of operative findings, the usual clinical appearance of pulmonary metastases rather than local recurrence, and early reports suggesting no decrease in survival in the absence of such irradiation.

Two year survival is again shown to be tantamount to cure. In contrast with most other reports, no statistically significant difference in survival rate could be shown at any age; this could not be attributed to the use of Dactinomycin in recent years.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1970 by the American Roentgen Ray Society.